---
figid: PMC4910120__cti201626f4
figtitle: Therapeutics in development target the IFN pathway in SLE
organisms:
- NA
pmcid: PMC4910120
filename: cti201626f4.jpg
figlink: /pmc/articles/PMC4910120/figure/fig4/
number: F4
caption: Therapeutics in development target the IFN pathway in SLE. Therapeutics targeting
  various aspects of the IFN pathway are in different stages of development, ranging
  from those that target the IFN producing cell, the pDC, to various parts of the
  IFN signaling machinery, IFN itself, or its receptor.
papertitle: 'Targeted therapeutics in SLE: emerging strategies to modulate the interferon
  pathway.'
reftext: Shereen Oon, et al. Clin Transl Immunology. 2016 May;5(5):e79.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8513491
figid_alias: PMC4910120__F4
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC4910120__F4
ndex: d8d4a3b3-de9c-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4910120__cti201626f4.html
  '@type': Dataset
  description: Therapeutics in development target the IFN pathway in SLE. Therapeutics
    targeting various aspects of the IFN pathway are in different stages of development,
    ranging from those that target the IFN producing cell, the pDC, to various parts
    of the IFN signaling machinery, IFN itself, or its receptor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DNASE1
  - IFNAR1
  - IFNAR2
  - TLR7
  - TLR9
  - JAK1
  - TYK2
  - JAK2
  - JAK3
  - MYD88
  - IFNA1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - IFN1@
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - PDC
  - PNKD
  - CLEC4C
  - Tofacitinib
  - ST-2825
  - hydroxychloroquine
---
